Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium
Status:
Completed
Trial end date:
2019-03-02
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy of topical 0.2% loteprednol
etabonate, a 'soft steroid', compared with topical 0.1% dexamethasone, which is widely used
in postoperative pterygium excision to prevent the recurrence of pterygium. If 0.2%
loteprednol etabonate is non-inferior in efficacy compared with 0.1% dexamethasone, it may be
used postoperatively in pterygium excision patients with the benefit of a low incidence of
ocular hypertension or secondary glaucoma.